Russell Investments Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.3M | Buy |
|
|||||
|
2025
Q2 | $4.37M | Buy |
|
|||||
|
2025
Q1 | $3.76M | Buy |
|
|||||
|
2024
Q4 | $2.91M | Sell |
|
|||||
|
2024
Q3 | $4.92M | Sell |
|
|||||
|
2024
Q2 | $6.41M | Sell |
|
|||||
|
2024
Q1 | $7.62M | Sell |
|
|||||
|
2023
Q4 | $9.59M | Buy |
|
|||||
|
2023
Q3 | $6.56M | Buy |
|
|||||
|
2023
Q2 | $7.85M | Sell |
|
|||||
|
2023
Q1 | $7.31M | Buy |
|
|||||
|
2022
Q4 | $5.08M | Buy |
|
|||||
|
2022
Q3 | $3.86M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $242K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $225K | Sell |
|
|||||
|
2021
Q2 | $1.77M | Sell |
|
|||||
|
2021
Q1 | $3.65M | Sell |
|
|||||
|
2020
Q4 | $5.47M | Sell |
|
|||||
|
2020
Q3 | $3.34M | Buy |
|
|||||
|
2020
Q2 | $2.65M | Sell |
|
|||||
|
2020
Q1 | $2.15M | Sell |
|
|||||
|
2019
Q4 | $2.65M | Buy |
|
|||||
|
2019
Q3 | $1.71M | Buy |
|
|||||
|
2019
Q2 | $2.52M | Buy |
|
|||||
|
2019
Q1 | $2.27M | Buy |
|
|||||
|
2018
Q4 | $1.19M | Sell |
|
|||||
|
2018
Q3 | $5.57M | Buy |
|
|||||
|
2018
Q2 | $2.13M | Sell |
|
|||||
|
2018
Q1 | $1.44M | Buy |
|
|||||
|
2017
Q4 | $1.18M | Sell |
|
|||||
|
2017
Q3 | $2.14M | Buy |
|
|||||
|
2017
Q2 | $1.94M | Buy |
|
|||||
|
2017
Q1 | $1.9M | Buy |
|
|||||
|
2016
Q4 | $927K | Buy |
|